The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation
Open accessAbstract
Integrins are the major adhesion receptors of leukocytes and platelets. β1 and β2 integrin function on leukocytes is crucial for a successful immune response and the platelet integrin αIIbβ3 initiates the process of blood clotting through binding fibrinogen. Integrins on circulating cells bind poorly to their ligands but become active after 'inside-out' signaling through other membrane receptors. Subjects with leukocyte adhesion deficiency-1 (LAD-I) do not express β2 integrins because of mutations in the gene specifying the β2 subunit, and they suffer recurrent bacterial infections. Mutations affecting αIIbβ3 integrin cause the bleeding disorder termed Glanzmann's thrombasthenia. Subjects with LAD-III show symptoms of both LAD-I and Glanzmann's thrombasthenia. Their hematopoietically-derived cells express β1, β2 and β3 integrins, but defective inside-out signaling causes immune deficiency and bleeding problems. The LAD-III lesion has been attributed to a C → A mutation in the gene encoding calcium and diacylglycerol guanine nucleotide exchange factor (CALDAGGEF1; official symbol RASGRP2) specifying the CALDAG-GEF1 protein, but we show that this change is not responsible for the LAD-III disorder. Instead, we identify mutations in the KINDLIN3 (official symbol FERMT3) gene specifying the KINDLIN-3 protein as the cause of LAD-III in Maltese and Turkish subjects. Two independent mutations result in decreased KINDLIN3 messenger RNA levels and loss of protein expression. Notably, transfection of the subjects' lymphocytes with KINDLIN3 complementary DNA but not CALDAGGEF1 cDNA reverses the LAD-III defect, restoring integrin-mediated adhesion and migration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Homing and cellular traffic in lymph nodes
von Andrian, U. H., & Mempel, T. R. (2003) · Nature Reviews Immunology · doi:10.1038/nri1222 · Cited by 1,281
LEUKOCYTE ADHESION DEFICIENCY: An Inherited Defect in the Mac-1, LFA-1, and p150,95 Glycoproteins
Anderson, D. C., & Springer, T. A. (1987) · Annual Review of Medicine · doi:10.1146/annurev.me.38.020187.001135 · Cited by 1,148
Kindlin-3 is essential for integrin activation and platelet aggregation
Moser, M., Nieswandt, B., Ussar, S., Pozgajova, M., & Fässler, R. (2008) · Nature Medicine · doi:10.1038/nm1722 · Cited by 700
Self-citationStructural Determinants of Integrin Recognition by Talin
Garcı́a-Alvarez, B., de Pereda, J. M., Calderwood, D. A., Ulmer, T. S., Critchley, D., Campbell, I. D., Ginsberg, M. H., & Liddington, R. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(02)00823-7 · Cited by 518
Intracellular signalling controlling integrin activation in lymphocytes
Kinashi, T. (2005) · Nature Reviews Immunology · doi:10.1038/nri1646 · Cited by 477
Kindlin-2 controls bidirectional signaling of integrins
Montanez, E., Ussar, S., Schifferer, M., Bösl, M., Zent, R., Moser, M., & Fässler, R. (2008) · Genes & Development · doi:10.1101/gad.469408 · Cited by 452
Self-citationThe Phosphotyrosine Binding-like Domain of Talin Activates Integrins
Calderwood, D. A., Yan, B., de Pereda, J. M., Alvarez, B. G., Fujioka, Y., Liddington, R. C., & Ginsberg, M. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111996200 · Cited by 412
CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation
Crittenden, J. R., Bergmeier, W., Zhang, Y., Piffath, C. L., Liang, Y., Wagner, D. D., Housman, D. E., & Graybiel, A. M. (2004) · Nature Medicine · doi:10.1038/nm1098 · Cited by 406
Kindlin-3 is required for β2 integrin–mediated leukocyte adhesion to endothelial cells
Moser, M., Bauer, M., Schmid, S., Ruppert, R., Schmidt, S., Sixt, M., Wang, H.-V., Sperandio, M., & Fässler, R. (2009) · Nature Medicine · doi:10.1038/nm.1921 · Cited by 367
Self-citationKindlin-2 (Mig-2): a co-activator of β3 integrins
Ma, Y.-Q., Qin, J., Wu, C., & Plow, E. F. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200710196 · Cited by 352
Coller, B. S., & Shattil, S. J. (2008) · Blood · doi:10.1182/blood-2008-06-077891 · Cited by 352
Siegel, D. H., Ashton, G. H. S., Penagos, H. G., Lee, J. V., Feiler, H. S., Wilhelmsen, K. C., South, A. P., Smith, F. J. D., Prescott, A. R., Wessagowit, V., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/376609 · Cited by 348
T-cell integrins: more than just sticking points
Hogg, N., Laschinger, M., Giles, K., & McDowall, A. (2003) · Journal of Cell Science · doi:10.1242/jcs.00876 · Cited by 322
Self-citationKindlins: essential regulators of integrin signalling and cell-matrix adhesion
Larjava, H., Plow, E. F., & Wu, C. (2008) · The EMBO Reports · doi:10.1038/embor.2008.202 · Cited by 268
Jobard, F. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg097 · Cited by 259
The Kindlins: Subcellular localization and expression during murine development
Ussar, S., Wang, H.-V., Linder, S., Fässler, R., & Moser, M. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.06.030 · Cited by 254
Self-citationKuijpers, T. W., Van Lier, R. A., Hamann, D., de Boer, M., Thung, L. Y., Weening, R. S., Verhoeven, A. J., & Roos, D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119697 · Cited by 233
A talin-dependent LFA-1 focal zone is formed by rapidly migrating T lymphocytes
Smith, A., Carrasco, Y. R., Stanley, P., Kieffer, N., Batista, F. D., & Hogg, N. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200412032 · Cited by 204
Self-citationBergmeier, W., Goerge, T., Wang, H.-W., Crittenden, J. R., Baldwin, A. C. W., Cifuni, S. M., Housman, D. E., Graybiel, A. M., & Wagner, D. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30575 · Cited by 191
Kloeker, S., Major, M. B., Calderwood, D. A., Ginsberg, M. H., Jones, D. A., & Beckerle, M. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307978200 · Cited by 163
Pasvolsky, R., Feigelson, S. W., Kilic, S. S., Simon, A. J., Tal-Lapidot, G., Grabovsky, V., Crittenden, J. R., Amariglio, N., Safran, M., Graybiel, A. M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070058 · Cited by 159
Kindlin-3: a new gene involved in the pathogenesis of LAD-III
Mory, A., Feigelson, S. W., Yaralı, N., Kılıç, S. Ş., Bayhan, G. İ., Gershoni‐Baruch, R., Etzioni, A., & Alon, R. (2008) · Blood · doi:10.1182/blood-2008-06-163162 · Cited by 144
Ghandour, H., Culleré, X., Álvarez, Á., Luscinskas, F. W., & Mayadas, T. N. (2007) · Blood · doi:10.1182/blood-2007-03-077628 · Cited by 132
Characterization of RasGRP2, a Plasma Membrane-targeted, Dual Specificity Ras/Rap Exchange Factor
Clyde-Smith, J., Silins, G., Gartside, M. G., Grimmond, S. M., Etheridge, M., Apolloni, A., Hayward, N. K., & Hancock, J. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006087200 · Cited by 130
Natural history and early diagnosis of LAD-1/variant syndrome
Kuijpers, T. W., van Bruggen, R., Kamerbeek, N. M., Tool, A. T. J., Hiçsönmez, G., Gürgey, A., Karow, A., Verhoeven, A. J., Seeger, K., Sanal, Ö., et al. (2006) · Blood · doi:10.1182/blood-2006-05-021402 · Cited by 118
Genetic analysis of integrin function in man: LAD-1 and other syndromes
Hogg, N., & Bates, P. A. (2000) · Matrix Biology · doi:10.1016/s0945-053x(00)00066-4 · Cited by 113
Self-citationThe talin–tail interaction places integrin activation on FERM ground
Campbell, I. D., & Ginsberg, M. H. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.06.005 · Cited by 108
A novel form of integrin dysfunction involving β1, β2, and β3 integrins
McDowall, A., Inwald, D. P., Leitinger, B., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314076 · Cited by 98
Self-citationAlon, R., Aker, M., Feigelson, S. W., Sokolovsky-Eisenberg, M., Staunton, D. E., Cinamon, G., Grabovsky, V., Shamri, R., & Etzioni, A. (2003) · Blood · doi:10.1182/blood-2002-11-3427 · Cited by 90
Weinstein, E. J., Bourner, M. J., Head, R., Zakeri, H., Bauer, C., & Mazzarella, R. A. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(03)00035-8 · Cited by 83
Regulation of Ras in lymphocytes: get a GRP
Stone, J. C. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340858 · Cited by 81
Non‐kinase second‐messenger signaling: new pathways with new promise
Springett, G., Kawasaki, H., & Spriggs, D. (2004) · Bioessays · doi:10.1002/bies.20057 · Cited by 78
Harris, E. S., Shigeoka, A. O., Li, W., Adams, R. H., Prescott, S. M., McIntyre, T. M., Zimmerman, G. A., & Lorant, D. E. (2001) · Blood · doi:10.1182/blood.v97.3.767 · Cited by 59
Etzioni, A., & Alon, R. (2004) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200412000-00003 · Cited by 57
Genetic analysis of integrin activation in T lymphocytes
Kellermann, S., Dell, C. L., Hunt, S. W., & Shimizu, Y. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18615.x · Cited by 13
Cited by
Barczyk, M., Carracedo, S., & Gullberg, D. (2010) · Cell and Tissue Research · doi:10.1007/s00441-009-0834-6 · Cited by 1,512
Extracellular vesicles as tools and targets in therapy for diseases
Kumar, M. A., Baba, S. K., Sadida, H. Q., Marzooqi, S. A., Jerobin, J., Altemani, F. H., Algehainy, N., Alanazi, M. A., Abou-Samra, A.-B., Kumar, R., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01735-1 · Cited by 1,343
The final steps of integrin activation: the end game
Shattil, S. J., Kim, C., & Ginsberg, M. H. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2871 · Cited by 1,086
How leukocytes cross the vascular endothelium
Vestweber, D. (2015) · Nature Reviews Immunology · doi:10.1038/nri3908 · Cited by 858
The Tail of Integrins, Talin, and Kindlins
Moser, M., Legate, K. R., Zent, R., & Fässler, R. (2009) · Science · doi:10.1126/science.1163865 · Cited by 760
Self-citation
Metadata
- Authors
- Svensson, L., Howarth, K., McDowall, A., Patzak, I., Evans, R., Ussar, S., Moser, M., Metin, A., Fried, M., Tomlinson, I., & Hogg, N.
- Venue
- Nature Medicine
- Published
- 2009-02-22
- Volume
- 15
- Issue
- 3
- Pages
- 306-312
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1982330320
- Cited by
- 421
- References
- 35
- FWCI
- 31.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.